Compounded GLP-1 Injections Spark Regulatory Battle Compounded GLP-1 injections are at the centre of a regulatory dispute. iDexis challenges SAHPRA and SAPC recall orders. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
